首页> 外国专利> COMPOSITIONS AND METHODS FOR TREATING PRESBYOPIA MILD HYPEROPIA AND IRREGULAR ASTIGMATISM

COMPOSITIONS AND METHODS FOR TREATING PRESBYOPIA MILD HYPEROPIA AND IRREGULAR ASTIGMATISM

机译:治疗老视,轻度过度和不规则散光的组合物和方法

摘要

The present invention relates to compositions and methods for treating eye diseases including presbyopia, mild hyperopia, irregular astigmatism, hyperopia adaptive esotropia, and glaucoma. The composition may also be used to enhance or enhance interventions that delay, reverse, or modify the aging process of the corrector and its surrounding tissues. The composition comprises choline agents such as muscarinic acetylcholine receptor M3 agonists, and alpha agonists with imidazoline groups or non-steroidal anti-inflammatory agents (NSAIDs) with COX-2 selectivity. Alpha agents with imidazoline groups or non-steroidal anti-inflammatory agents (NSAIDs) with COX-2 selectivity, together with choline agents such as pilocarpine, have the ability to adapt and focus the eye while minimizing side effects from each compound. It has been found to be synergistic to improve.
机译:本发明涉及用于治疗包括老花眼,轻度远视,不规则散光,远视适应性内斜视和青光眼的眼病的组合物和方法。所述组合物还可用于增强或增强延迟,逆转或改变校正剂及其周围组织的衰老过程的干预。该组合物包含胆碱剂,例如毒蕈碱乙酰胆碱受体M3激动剂和具有咪唑啉基团的α激动剂或具有COX-2选择性的非甾体抗炎剂(NSAID)。具有咪唑啉基团的α药剂或具有COX-2选择性的非甾体抗炎药(NSAID),与胆碱药剂(例如毛果芸香碱)一起具有使眼睛适应和聚焦的能力,同时最大程度地减少了每种化合物的副作用。已经发现改善是协同的。

著录项

  • 公开/公告号KR102017916B1

    专利类型

  • 公开/公告日2019-09-03

    原文格式PDF

  • 申请/专利权人 알러간 인코포레이티드;

    申请/专利号KR20147010384

  • 发明设计人 아바드 자운 카를로스;

    申请日2012-09-19

  • 分类号A61K31/27;A61K31/4164;A61K31/4178;A61K31/5415;A61P27/06;

  • 国家 KR

  • 入库时间 2022-08-21 11:47:51

相似文献

  • 专利
  • 外文文献
  • 中文文献
获取专利

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号